BCL10 Polyclonal Antibody

Elabscience
Product Code: E-AB-14787
Product Group: Primary Antibodies
Supplier: Elabscience
CodeSizePrice
E-AB-14787-20uL20uL£125.00
Quantity:
E-AB-14787-60uL60uL£172.00
Quantity:
E-AB-14787-120uL120uL£237.00
Quantity:
E-AB-14787-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
  • Rat
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
Ice packs
Storage:
-20°C

Images

1 / 2
Immunohistochemistry of paraffin-embedded Human thyroid cancer using BCL10 Polyclonal Antibody at dilution of 1:40
2 / 2
Immunohistochemistry of paraffin-embedded Human gastric cancer using BCL10 Polyclonal Antibody at dilution of 1:40

Immunohistochemistry of paraffin-embedded Human thyroid cancer using BCL10 Polyclonal Antibody at dilution of 1:40
Immunohistochemistry of paraffin-embedded Human gastric cancer using BCL10 Polyclonal Antibody at dilution of 1:40

Documents

Further Information

Abbreviation:
BCL10
Background:
This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Calculated MW:
26kDa
Concentration:
0.4 mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000, IHC 1:25-1:100
Immunogen:
Recombinant protein of human BCL10
Purification method:
Affinity purification
Target Synonym:
AI132454;B cell CLL/lymphoma 10;B cell lymphoma/leukemia10;B-cell CLL/lymphoma 10;B-cell leukemia/lymphoma 10;B-cell lymphoma/leukemia 10;Bcl 10;Bcl-10;Bcl10;BCL10;c E10;c-E10;C81403;CARD containing apoptotic signaling protein;CARD containing molecule enhancing NF kappa B;CARD containing molecule enhancing NF kB;CARD containing molecule enhancing NF-kB;CARD containing molecule enhancing NFkB;CARD containing proapoptotic protein;CARD like apoptotic protein;CARD-containing apoptotic signaling protein;CARD-containing molecule enhancing NF-kappa-B;CARD-containing proapoptotic protein;CARD-like apoptotic protein;CARMEN;Caspase recruiting domain containing protein;caspase-recruiting domain-containing protein;cCARMEN;cE 10;cE10;CED 3/ICH 1 prodomain homologous E10 like regulator;CED-3/ICH-1 prodomain homologous E10-like regulator;CED3/ICH1 prodomain homologous E10 like regulator;Cellular E10;Cellular homolog of vCARMEN;Cellular-E10;CIPER;CLAP;hCLAP;Mammalian CARD containing adapter molecule E10;Mammalian CARD-containing adapter molecule E10;mE 10;mE10;R-RCD1
UNIProt ID:
O95999